Researchers at the University of Nottingham have developed a new genetic test that can diagnose brain tumours in as little as 2 hours The test, called ROBIN, uses PromethION nanopore sequencing to deliver rapid methylome classification. The researchers said results could be available intraoperatively, allowing clinicians to make faster, more informed decisions. The same assay … Read more
Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs keysnews.com Weight-loss jab Mounjaro helps people shed much more weight than rival – study Irish Examiner Better Than Ozempic: Scientists Reveal Most Effective Weight Loss Drug SciTechDaily Source link
Patients with early Alzheimer’s disease (AD) who initiated lecanemab treatment at a specialty memory clinic showed an expected and manageable side-effect profile, new research showed. “The findings are very reassuring,” Barbara Joy Snider, MD, PhD, professor of neurology, and director of the Memory Diagnostic Center and Knight ADRC Clinical Trials Unit, Washington University School of … Read more
image: ©Halfpoint | iStock A new study published in the European Heart Journal reveals that adults diagnosed with type 1 diabetes face a heightened risk of cardiovascular disease and death, with no better prognosis than those diagnosed in childhood Research on type 1 diabetes in adults remains limited, prompting researchers at Karolinska Institutet to investigate … Read more
SAN DIEGO—Gastroenterologists have debated the best course of action for patients with Barrett’s esophagus for decades. Which is better for detecting early malignancy and preventing progression to esophageal adenocarcinoma (EAC) — surveillance endoscopy at regular intervals or only when symptoms occur? Does one offer a better chance of survival than the other? Now, researchers who … Read more
For the first time, the number of Americans living with Alzheimer’s disease (AD) has surpassed 7 million, according to the Alzheimer’s Disease Facts and Figures report released this week. An estimated 7.2 million people aged 65 years or older are now living with AD, up from an estimated 6.9 million in the 2024 report. Three … Read more
TOPLINE: In patients with type 2 diabetes (T2D), combination therapy with glucagon-like peptide 1 receptor agonists (GLP-1 RAs) and thiazolidinediones was associated with a reduced risk for all-cause mortality, cardiovascular mortality, and major adverse cardiovascular events (MACEs) compared with those who used none or one of these therapies. METHODOLOGY: For people with T2D, the potential … Read more
A new social media trend is making headlines: Methylene blue is being touted as a cognitive booster and antiaging miracle. Influencers such as Ben Greenfield are promoting the use of this chemical to enhance brain performance, strengthen the immune system, and even prevent cancer without providing scientific evidence. Researchers have warned that methylene blue can … Read more
Weight-loss jabs and those for diabetes may be linked to a lower risk of dementia, a study suggests. Semaglutide in particular, whose brand names include Wegovy and Ozempic, showed promise in cutting the risk of conditions that impair memory and thought processes, according to researchers. Experts called for further research to shed light on how … Read more
The use of smoking cessation medications during the first trimester of pregnancy posed no greater risk for major congenital malformations (MCMs) in infants than smoking, based on a meta-analysis of approximately 400,000 infants. “Maternal smoking during pregnancy is the leading cause of harms to both mother and baby, contributing to outcomes such as preterm birth, … Read more